ArticleCardioprotective effect Linagliptin (DPP-4 Inhibitor) against myocardial infarction induced in rats with metabolic syndrome
ArticleCardioprotective effect Linagliptin (DPP-4 Inhibitor) against myocardial infarction induced in rats with metabolic syndrome
ArticleTHE POTENTIAL MODULATING IMPACT OF THE DIPEPTIDYL PEPTIDASE-4 (DPP-4) INHIBITOR, SITAGLIPTIN ON STREPTOZOTOCIN-NICOTINAMIDE-INDUCED DIABETIC NEPHROPATHY IN RATS
ArticleTHE POTENTIAL MODULATING IMPACT OF THE DIPEPTIDYL PEPTIDASE-4 (DPP-4) INHIBITOR, SITAGLIPTIN ON STREPTOZOTOCIN-NICOTINAMIDE-INDUCED DIABETIC NEPHROPATHY IN RATS
ArticleCILOSTAZOL ATTENUATES DIABETIC NEPHROPATHY IN RATS VIA ELEVATION OF PLASMA SOLUBLE RECEPTOR FOR ADVANCED GLYCATION END-PRODUCTS
ArticleCILOSTAZOL ATTENUATES DIABETIC NEPHROPATHY IN RATS VIA ELEVATION OF PLASMA SOLUBLE RECEPTOR FOR ADVANCED GLYCATION END-PRODUCTS
ArticleA DIHYDROCHALCONE AND SGLT2 INHIBITOR ABATE METHOTREXATE HEPATOTOXICITY IN MALE RATS; A COMPARATIVE STUDY
ArticleA DIHYDROCHALCONE AND SGLT2 INHIBITOR ABATE METHOTREXATE HEPATOTOXICITY IN MALE RATS; A COMPARATIVE STUDY
ArticlePROTECTIVE EFFECT OF SOME RENIN INHIBITORS IN ACUTE NEPHROTOXICITY INDUCED BY SOME ANTICARCINOGENIC DRUGS IN RATS
ArticlePROTECTIVE EFFECT OF SOME RENIN INHIBITORS IN ACUTE NEPHROTOXICITY INDUCED BY SOME ANTICARCINOGENIC DRUGS IN RATS
ArticleProtective effect of dapagliflozin against non-alcoholic fatty liver in rats AMPK/SIRT1 pathway activation
ArticleProtective effect of dapagliflozin against non-alcoholic fatty liver in rats AMPK/SIRT1 pathway activation